Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_assertion type Assertion NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_head.
- NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_assertion description "[Our main findings were: (1) serum levels of all Wnt modulators were markedly elevated in patients with symptomatic AS (mean increase 231% to 278%, P<0.001), (2) all Wnt modulators were present in calcified aortic valves but correlated poorly with systemic levels or degree of AS, (3) some modulators (ie, WIF-1) were associated with the degree of myocardial function and valvular calcification, (4) all Wnt modulators, and DKK-1 in particular, predicted long-term mortality in these patients also after adjusting for conventional predictors including NT-proBNP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_provenance.
- NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_assertion evidence source_evidence_literature NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_provenance.
- NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_assertion SIO_000772 23316316 NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_provenance.
- NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_assertion wasDerivedFrom befree-2016 NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_provenance.
- NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_assertion wasGeneratedBy ECO_0000203 NP1043388.RA0AWtBRzA_dVAQWzmvuUh6zBIqAfa1B-2Gq9e1GS5p6A130_provenance.